Treatment Tapering in JIA With Inactive Disease

NCT02840175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Idiopathic Arthritis

Interventions

DRUG: etanercept
DRUG: adalimumab
DRUG: Abatacept
DRUG: Tocilizumab

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]